Taken together, these results represent the first evidence that a protective adaptive immune response against OSCC, the most frequent tumor of the oral cavity, may be elicited in vivo by inducing the tumor cells to express MHC-II molecules in a CIITA-dependent manner. Here, CIITA is linked to neoplasm.